Pharmaceutical

Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs

Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and...

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc

The report from The Insight Partners lists several stakeholders—including pharmaceutical and biotech companies, CROs, regulatory authorities, healthcare providers, and academic...

Natural Language Processing (NLP) In Healthcare And Life Sciences Market is expected to generate a revenue of USD 9.57 Billion by 2031, Globally, at 19.82% CAGR: Verified Market Research®

Patient Controlled Injectors Market Size Set for Explosive Growth, With Projections Indicating $ 12.33 billion by 2031 | The Insight Partners

The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic...

Healthcare Revenue Cycle Management (RCM) Market Surges to USD 658.7 Billion by 2030, Propelled by 24% CAGR – Verified Market Reports®

Verified Market Reports®, a trusted name in market intelligence, is excited to announce the launch of its latest report, "Healthcare...

Positioned for growth, patient recruitment company 1nHealth appoints Kayt Leonard as its first chief commercial officer

ORLANDO, Fla., Dec. 13, 2024 /PRNewswire/ -- 1nHealth, a digital patient recruitment company accelerating enrollment for clinical trials, announces the appointment...

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health’s Crofelemer

Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -...

error: Content is protected !!